NCI Launches Registry for Very Rare Childhood Cancers to Inform Future Treatments
The National Cancer Institute has initiated a registry to collect data on very rare cancers in children, teens, and young adults.
Indication
Clinical and regulatory intelligence for Rare Cancers with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No related entities indexed yet.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.